Key result
The presence of fragmented QRS complexes on routine 12-lead electrocardiography was associated with a significantly increased risk of total mortality (RR 3.09) and major adverse cardiac events (RR 2.85) in patients with coronary artery disease.
Why the study?
Does the presence of fragmented QRS complex on ECG predict total mortality and MACE in patients with coronary artery disease?
Meta-Analysis (n=3,279)
Does the presence of fragmented QRS complex on ECG predict total mortality and MACE in patients with coronary artery disease?
Relative Risk: 3.09 (95% CI 1.76–5.44)
p-value: p=<0.0001
The presence of a fragmented QRS complex on ECG is a significant predictor of increased total mortality, MACE, and adverse echocardiographic remodeling parameters in patients with coronary artery disease.
May refine CAD risk stratification; hypothesis-generating and should not yet change practice.
BACKGROUND: Fragmented QRS complex (fQRS), an easily evaluated noninvasive electrocardiographic parameter, is associated with worse outcomes in patients with several cardiovascular conditions. The presence of fQRS on ECG may be an indicator of myocardial damage in patients with coronary artery disease (CAD). In this article, we performed a meta-analysis in order to characterize the presence of fQRS on ECG in patients with CAD. METHODS: We searched English-language randomized controlled trials involving fQRS on ECG in patients with CAD (n = 3279 patients, 12 trials). Two reviewers independently extracted data. Data on LVEF, LVESD, LVEDD, LVESV, LVEDV, total mortality, stroke, and MACE were collected. fQRS was performed a comparison with non-fQRS, calculating pooled relatives risk (RRs) and weighted mean difference (WMD), and associated 95% confidence intervals (CIs). RESULTS: fQRS was associated with significant increased WMD of LVEDD (WMD, 2.26; 95%CI, 0.92 to 0.36, P = 0.0009), LVESD (WMD, 2.71; 95%CI, 1.23 to 4.19, P = 0.0003), LVEDV (WMD, 31.37; 95%CI, 24.82 to 37.92, P < 0.00001), and LVESV (WMD, 28.45; 95%CI, 22.92 to 33.98, P < 0.00001). As compared to non-fQRS, fQRS increased risk of total mortality (RR, 3.09; 95%CI, 1.76 to 5.44, P < 0.0001) and MACE (RR, 2.85; 95%CI, 1.98 to 4.09, P < 0.00001) in patients with CAD. However, a decreased trend was observed for LVEF (WMD, -3.59; 95%CI, -7.05 to -0.12, P = 0.04). For the incidence of stoke, there was no difference between fQRS and non-fQRS group. CONCLUSIONS: Our findings indicate that fQRS is a valuable factor to predict total mortality and MACE in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Gong et al. (2015) conducted a meta-analysis in Coronary artery disease (n=3,279). Fragmented QRS complex (fQRS) vs. Non-fQRS was evaluated on Total mortality (RR 3.09, 95% CI 1.76 to 5.44, p=<0.0001). The presence of fragmented QRS complexes on routine 12-lead electrocardiography was associated with a significantly increased risk of total mortality (RR 3.09) and major adverse cardiac events (RR 2.85) in patients with coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: